Saphnelo, with the active ingredient anifrolumab, is a medication that was approved by the U.S. Food and Drug Administration (FDA) for the treatment of systemic lupus erythematosus (SLE) in adults.
$6,116.00
Select optionsThis product has multiple variants. The options may be chosen on the product page